Gus Gazzard

Affiliation

Moorfields Eye Hospital NHS Foundation Trust

Biography

Professor Gus Gazzard was made a Consultant in the Glaucoma Service at Moorfields Eye Hospital in 2009 after a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw in Singapore 1999-2002, where he ran and established several randomised clinical trials (including the Singapore-5FU and the ACLIPS trials, both published in Ophthalmology). In 2012 he established, as Chief Investigator, the 6-year NIHR-HTA funded (£2.5m) multi-centre LiGHT trial of selective laser trabeculoplasty which reported 3-year results in The Lancet 2019 and completed in 2021. Gus’ research interests include angle closure glaucoma, selective laser trabeculoplasty, randomised controlled trials of glaucoma treatments, anterior segment imaging and the epidemiology of myopia. He was a member of the EAGLE Study Group (an international multi-centre RCT of early lens extraction in angle-closure), on the advisory board for the ZAP trial (an RCT assessing prophylactic laser iridotomy) - both published in The Lancet - and founded the European Glaucoma Society Angle Closure Special Interest Group. He is UCL Professor of Ophthalmology and Director for Moorfields Glaucoma Service, responsible for 130,000 patient visits a year.